↓ Skip to main content

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2…

Overview of attention for article published in Frontiers in immunology, August 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
20 Mendeley